Clinic
Fairview Clinics
Fairview Clinics was paid $2.16M by Medicaid between Jan 2018 and Dec 2024, across 76 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.
33Billing provider infoFAIRVIEW CLINICS
BLAINE, MN 55449
BLAINE, MN 55449
33aNPI1972784205assigned 11/15/2007
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$2.16M
24GClaims65,810
24DCodes billed76
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Minnesota
Rank by total paid#31 of 87
Median peer was paid$1.04M
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official RING, MAUREEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,048 | $70K | |
| 2019 | 8,012 | $266K | |
| 2020 | 8,063 | $299K | |
| 2021 | 13,692 | $466K | |
| 2022 | 10,164 | $391K | |
| 2023 | 9,880 | $369K | |
| 2024incomplete | 7,951 | $297K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 12,741 | 11,687 | $874K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 12,185 | 11,346 | $622K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 8.7% | 3,264 | 3,184 | $188K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 733 | 721 | $58K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 696 | 681 | $53K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.4% | 4,344 | 4,212 | $51K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 509 | 502 | $35K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 8,946 | 8,349 | $34K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.5% | 1,999 | 1,956 | $32K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.4% | 438 | 405 | $30K |
| 80061 | Lipid panel | <1% | 1,303 | 1,274 | $15K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 605 | 594 | $15K |
64 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,002 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 90 | $10K |
| 96127 | <1% | 2,404 | $9K | |
| 80053 | Comprehensive metabolic panel | <1% | 921 | $8K |
| 92551 | <1% | 1,254 | $7K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 75 | $6K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 780 | $6K |
| 90686 | <1% | 1,728 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 624 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 903 | $5K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 324 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 52 | $5K |
| 99188 | <1% | 923 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 535 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 54 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 171 | $3K |
| X5622 | <1% | 571 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 756 | $3K |
| 86803 | <1% | 220 | $3K | |
| 85027 | <1% | 475 | $3K | |
| 80306 | <1% | 183 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 96 | $2K |
| 99442 | <1% | 108 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 86 | $2K |
| 99000 | <1% | 164 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 259 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 45 | $2K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $2K |
| 99443 | <1% | 61 | $2K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 16 | $2K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 13 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 16 | $2K |
| 99173 | <1% | 1,286 | $1K | |
| 90715 | <1% | 101 | $1K | |
| 90651 | <1% | 47 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 28 | $971.48 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 27 | $938.11 |
| 0004A | <1% | 27 | $784.22 | |
| 90670 | <1% | 190 | $773.88 | |
| 90480 | <1% | 34 | $713.36 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 38 | $695.18 |
| 36416 | <1% | 250 | $687.83 | |
| 87081 | <1% | 164 | $653.85 | |
| 90682 | <1% | 13 | $631.32 | |
| 71250 | <1% | 14 | $630.43 | |
| 81001 | <1% | 131 | $392.96 | |
| 82043 | <1% | 78 | $388.74 | |
| 81025 | <1% | 39 | $316.21 | |
| 90461 | <1% | 13 | $223.80 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 14 | $220.17 |
| 90698 | <1% | 92 | $214.29 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 193 | $187.05 |
| 87210 | <1% | 25 | $135.39 | |
| 93000 | <1% | 12 | $112.35 | |
| 85610 | <1% | 26 | $109.40 | |
| 90656 | <1% | 117 | $97.36 | |
| 96161 | <1% | 41 | $58.77 | |
| 99459 | 0% | 19 | $0.00 | |
| 90677 | 0% | 40 | $0.00 | |
| 90697 | 0% | 14 | $0.00 | |
| 90680 | 0% | 12 | $0.00 | |
| 99421 | 0% | 12 | $0.00 | |
| 90685 | 0% | 14 | $0.00 | |
| 90633 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRING, MAUREEN (SYS DIR GOVT REIMB & NETWK REL)
| Provider | Location | Paid |
|---|---|---|
| Fairview Health Services | Minneapolis, MN | $90.41M |
| Fairview Health Services | Saint Paul, MN | $48.52M |
| Fairview Health Services | Burnsville, MN | $29.98M |
| Fairview Health Services | Minneapolis, MN | $26.56M |
| Healtheast ST. John's Hospital | Maplewood, MN | $17.91M |
| Fairview Health Services | Edina, MN | $17.24M |
| Healtheast Medical Research Institute | Saint Paul, MN | $11.37M |
| Fairview Clinics | Bloomington, MN | $9.40M |
| Fairview Health Services | Princeton, MN | $9.36M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.76M |
| Healtheast Medical Research Institute | Saint Paul, MN | $8.29M |
| Fairview Clinics | Brooklyn Park, MN | $8.06M |
| Fairview Health Services | Wyoming, MN | $7.71M |
| Healtheast Medical Research Institute | Maplewood, MN | $7.44M |
| Healtheast Woodwinds Hospital | Woodbury, MN | $6.17M |
| Fairview Clinics | Burnsville, MN | $4.75M |
| Fairview Clinics | Minneapolis, MN | $4.75M |
| Fairview Express Care | Saint Paul, MN | $4.57M |
| Fairview Clinics | Saint Paul, MN | $4.37M |
| Healtheast Medical Research Institute | Woodbury, MN | $4.07M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.